TNF-alpha expression in painful and nonpainful neuropathies

Neurology

Volumn 56, Issue 10, 2001, Pages 1371-1377

  Empl, Monika ^a,b   Renaud, S ^a   Erne, B ^a   Fuhr, P ^a   Straube, A ^b   Schaeren Wiemers, N ^a   Steck, A J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHWANN CELL;

EID: 0035933188     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.10.1371     Document Type: Article

References (22)

1. Lashbrook JM, Ossipov MH, Hunter JC, et al. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1-and COX2-inhibitors in nerve-injured rats. Pain 1999;82:65-72.
2. Sorkin LS, Xiao WH, Wagner R, et al. Tumor necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibers. Neuroscience 1997;81:255-262.
3. Watkins LR, Goehler LE, Relton J, et al. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 1995;692:244-250.
4. Cunha FQ, Poole S, Lorenzetti BB, et al. The pivotal role of tumor necrosis factor-alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-664.
5. Ignatowski TA, Covey WC, Knight PR, et al. Brain-derived TNF-alpha mediates neuropathic pain. Brain Res 1999;841: 70-77.
6. Sommer C, Schmidt C, George A. Hyperalgesia in experimental neuropathy is dependent on the TNF-receptor I. Exp Neurol 1998;151:138-142.
7. Sommer C. Tierexperimentelle Untersuchungen bei neuropathischem Schmerz. Schmerz 1999;13:315-323.
8. DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 1997;759:50-57.
9. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
10. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
11. Stein C, Mendl G. The German counterpart to McGill pain questionnaire. Pain 1988;32:251-255.
12. Mathey EK, Pollard JD, Armati PJ. TNF-alpha, IFN-gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 1999;163:47-52.
13. Oka N, Akiguchi I, Kawasaki T, et al. Tumor necrosis factor-alpha in peripheral nerve lesions. Acta Neuropathol 1998;95: 57-62.
14. Wagner R, Janjigian M, Myers RR. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 1998;74:35-42.
15. Kanaan SA, Poole S, Saadé NE, et al. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J Neuroimmunol 1998;86:142-150.
16. Gold MS. Spinal nerve ligation: what to blame for the pain and why. Pain 2000;84:117-120.
17. Llewelyn JG, Gilbey SG, Thomas PK, et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. Brain 1991;114:867-892.
18. Britland ST, Young RJ, Sharma AK, et al. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990;39:898-908.
19. George A, Schmidt C, Weishaupt A, et al. Serial determination of tumor-necrosis-factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 1999;160:124-132.
20. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999;57:1-164.
21. Hermann GE, Tovar CA, Rogers RC. Induction of endogenous tumor necrosis factor-alpha: suppression of centrally stimulated gastric motility. Am J Physiol 1999;276:R59-R68.
22. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Fact Rev 1996;7:231-240.